JP2025512110A5 - - Google Patents

Info

Publication number
JP2025512110A5
JP2025512110A5 JP2024560625A JP2024560625A JP2025512110A5 JP 2025512110 A5 JP2025512110 A5 JP 2025512110A5 JP 2024560625 A JP2024560625 A JP 2024560625A JP 2024560625 A JP2024560625 A JP 2024560625A JP 2025512110 A5 JP2025512110 A5 JP 2025512110A5
Authority
JP
Japan
Prior art keywords
group
alkyl
groups
alkyl group
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024560625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025512110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/088459 external-priority patent/WO2023198200A1/zh
Publication of JP2025512110A publication Critical patent/JP2025512110A/ja
Publication of JP2025512110A5 publication Critical patent/JP2025512110A5/ja
Pending legal-status Critical Current

Links

JP2024560625A 2022-04-14 2023-04-14 複合体及び組成物並びに製造方法及び使用 Pending JP2025512110A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN202210377179 2022-04-14
CN202210386579 2022-04-14
CN202210377179.7 2022-04-14
CN202210401035.0 2022-04-14
CN202210386579.4 2022-04-14
CN202210401035 2022-04-14
PCT/CN2023/088459 WO2023198200A1 (zh) 2022-04-14 2023-04-14 缀合物与组合物及制备方法和用途

Publications (2)

Publication Number Publication Date
JP2025512110A JP2025512110A (ja) 2025-04-16
JP2025512110A5 true JP2025512110A5 (enExample) 2026-04-22

Family

ID=88329094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024560625A Pending JP2025512110A (ja) 2022-04-14 2023-04-14 複合体及び組成物並びに製造方法及び使用

Country Status (8)

Country Link
US (1) US20250332268A1 (enExample)
EP (1) EP4509139A4 (enExample)
JP (1) JP2025512110A (enExample)
KR (1) KR20250004765A (enExample)
CN (1) CN118434451A (enExample)
AU (1) AU2023253037A1 (enExample)
CA (1) CA3246696A1 (enExample)
WO (1) WO2023198200A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025077871A1 (zh) * 2023-10-13 2025-04-17 苏州瑞博生物技术股份有限公司 缀合物、药物缀合物与组合物及制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103380113B (zh) 2010-11-15 2018-03-30 生命科技公司 含胺的转染试剂及其制备和使用方法
AU2014293670B2 (en) * 2013-07-23 2019-08-01 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
KR102015524B1 (ko) * 2016-12-26 2019-08-29 인터올리고 주식회사 압타머-약물 콘쥬게이트 및 그 용도
AU2018394875B2 (en) * 2017-12-29 2023-08-03 Suzhou Ribo Life Science Co., Ltd. Conjugates and preparation and use thereof
CN112390835A (zh) * 2019-08-14 2021-02-23 苏州瑞博生物技术股份有限公司 肝靶向化合物及缀合物
CN110760516B (zh) * 2019-11-12 2022-09-13 赣南医学院 核酸适配体衍生物和氨基化的核酸适配体衍生物以及它们的应用和药物偶合物

Similar Documents

Publication Publication Date Title
JP2022512643A5 (enExample)
JP5749273B2 (ja) 抗がん剤送達のためのポリマー系
JP2007527714A5 (enExample)
JP2020536847A5 (enExample)
JP2020536845A5 (enExample)
JP2022520792A5 (enExample)
JP2021510698A5 (enExample)
JP2021502120A5 (enExample)
JP5866301B2 (ja) 増殖及びタンパク質合成の細胞内ターゲッティングのためのポリアニオン性多価高分子
JP2004530657A5 (enExample)
CA2223989A1 (en) Prodrugs of pharmaceuticals with improved bioavailability
EP2029597A2 (en) Purine analogs
JPWO2008010463A1 (ja) コンブレタスタチン類の高分子結合体
JP2003506319A (ja) ビタミンに関連したデュアルターゲッティング治療法
JP2022553702A5 (enExample)
JPWO2009136572A1 (ja) 葉酸若しくは葉酸誘導体の高分子結合体
JP2025512110A5 (enExample)
JP2009541225A5 (enExample)
US20210100910A1 (en) Macromolecules
RU2623441C2 (ru) Конъюгаты антагонистов интегрина для нацеленной доставки к клеткам, экспрессирующим альфа-v-бета-3
WO2007011217A2 (en) Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes
RU2009121626A (ru) Соединения агонисты рецептора глюкагоноподобного белка-1 (glp-1r)
JP2024534502A5 (enExample)
JPWO2023163234A5 (enExample)
JP2020500148A (ja) 新規細胞傷害性剤およびそのコンジュゲート